本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Reneo Pharmaceuticals, Inc.

18.20
0.0000
成交量:- -
成交額:79.46萬
市值:6,084.04萬
市盈率:-10.81
高:18.20
開:18.20
低:18.20
收:18.20
52周最高:18.20
52周最低:0.9801
股本:334.29萬
流通股本:110.30萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.6843
每股收益(LYR):-2.5227
淨資產收益率:-54.00%
總資產收益率:-33.72%
市淨率:0.79
市盈率(LYR):-7.21

資料載入中...

2024/10/11

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/11

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/11

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/11

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/10

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/10

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/09

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/09

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/08

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/08

重要事件披露

Form 8-K - Current report
2024/10/02

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/10/02

重要事件披露

Form 8-K - Current report
2024/09/26

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/20

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2024/09/20

重要事件披露

Form 8-K - Current report
2024/09/13

重要事件披露

Form 8-K - Current report
2024/08/24

SEC問詢函

Form CORRESP - Correspondence
2024/08/19

SEC問詢函

Form CORRESP - Correspondence
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report